Market Research Logo

Drug Delivery Products

Drug Delivery Products

Drug delivery product demand in the US is projected to expand to $251 billion in 2019, with annual growth of 6.1 percent. As the US population expands and ages, domestic manufacturing and consumption of ethical and over-the-counter medicines and nutritional preparations are expected to rise. Commercialization of drug delivery systems and technologies will increase as generic and private label competition intensifies, drug patent protections expire, and pressure grows to hold down medication prices.

This report segments the drug delivery product market by Oral Products, Parenteral Products, and Other Products. These include:
Oral Products: Controlled-release, chewable, nanoparticulate, orally disintegrating, and transmucosal (or buccal) classifications
Parenteral Products: therapeutic monoclonal antibodies, encapsulated systems, infusion systems, and parenteral delivery devices
Other Products: inhalation, transdermal, and implantable therapies

Oral dosage formulations have historically comprised the largest selling group of drug delivery products, and will remain that way through 2019. Total growth will be somewhat hampered by increasing generic competition and reduced pricing flexibility. Parenteral products, including pen injectors and retractable pre-fillable syringes, are expected to post rapid gains as new and existing therapies based monoclonal antibodies contribute to improved effectiveness of treatment for cancer and other long-term disorders.

Therapeutic classes for drug delivery products include the following agents:
Central nervous system
Hormones and related
Respiratory
Cardiovascular
Gastrointestinal
Nutritional
Other Pharmaceutical

Central nervous system agents control the largest slice of demand for drug delivery product market by therapeutic class, accounting for more than 25 percent of sales. This trend is expected to continue as treatment of psychological and neurological disorders through continuous dosing, controlled-release medicines becomes increasingly prevalent.

This study also details market share and sales estimates for 30 key participants in the drug delivery products industry. These include Allergan, Animas, AstraZeneca, CareFusion, Evonik, GlaxoSmithKline, Hospira, Johnson & Johnson, Novartis, Pfizer, and Roche.


  • INTRODUCTION
  • EXECUTIVE SUMMARY
    • Table DRUG DELIVERY PRODUCT DEMAND
  • MARKET ENVIRONMENT
    • General
    • Economic Factors
      • Table MACROECONOMIC INDICATORS
    • Demographic Patterns
      • Table RESIDENT POPULATION BY AGE GROUP
    • Healthcare Trends
      • Health Insurance Reforms
        • Table HEALTH INSURANCE COVERAGE OF THE US POPULATION, 2004-2014
      • Medical Conditions
        • Table ACUTE CONDITIONS BY TYPE
        • Table CHRONIC CONDITIONS BY TYPE
      • National Health Expenditures
        • Table NATIONAL HEALTH EXPENDITURES BY SPENDING CATEGORY
        • Table NATIONAL HEALTH EXPENDITURES BY FUNDING SOURCE
      • Medical Providers
        • Table MEDICAL PROVIDERS BY TYPE
      • Patient Activity
        • Table PATIENT ACTIVITY BY TYPE
    • Pharmaceutical Industry Overview
      • Regulation
      • Research & Development
      • Product Demand
        • Table PHARMACEUTICAL DEMAND BY THERAPEUTIC CLASS
        • Table PHARMACEUTICAL DEMAND BY DOSAGE FORMULATION
        • Table PHARMACEUTICAL DEMAND BY REGULATORY CLASSIFICATION
        • Table PHARMACEUTICAL DEMAND BY PATENT STATUS
  • DRUG DELIVERY PRODUCT OVERVIEW
    • General
      • Table DRUG DELIVERY PRODUCT DEMAND BY TYPE
    • Types of Drug Delivery Products
      • Table CHART III-1 DRUG DELIVERY PRODUCT DEMAND BY TYPE, 2014
    • Historical Market Trends
      • Table DRUG DELIVERY PRODUCT DEMAND PATTERNS, 2004-2014
    • US Trade
      • Table US TRADE IN DRUG DELIVERY PRODUCTS
    • International Markets
      • Table WORLD DRUG DELIVERY PRODUCT DEMAND BY REGION
  • ORAL DRUG DELIVERY PRODUCTS
    • General
      • Table ORAL DRUG DELIVERY PRODUCT DEMAND BY TYPE
    • Controlled-Release Formulations
      • Table CONTROLLED-RELEASE ORAL DRUG DELIVERY PRODUCT DEMAND
      • Film-Coated Formulations
        • Table FILM-COATED ORAL DRUG DELIVERY PRODUCT DEMAND
      • Diffusion Formulations
        • Table DIFFUSION ORAL DRUG DELIVERY PRODUCT DEMAND
      • Reservoir Formulations
        • Table RESERVOIR ORAL DRUG DELIVERY PRODUCT DEMAND
    • Chewable Tablets
      • Table CHEWABLE TABLET PRODUCT DEMAND BY THERAPEUTIC CLASS
    • Orally Disintegrating Tablets
      • Table ORALLY DISINTEGRATING TABLET DEMAND BY THERAPEUTIC CLASS
    • Nanoparticulate Formulations
      • Table ORAL NANOPARTICULATE DRUG DELIVERY PRODUCT DEMAND BY THERAPEUTIC CLASS
    • Transmucosal Formulations
      • Table TRANSMUCOSAL DRUG DELIVERY PRODUCT DEMAND BY THERAPEUTIC CLASS
  • PARENTERAL DRUG DELIVERY PRODUCTS
    • General
      • Table PARENTERAL DRUG DELIVERY PRODUCT DEMAND BY TYPE
      • Table CHART V-1 PARENTERAL DRUG DELIVERY PRODUCT DEMAND BY TYPE, 2014
    • Therapeutic Monoclonal Antibodies
      • Table THERAPEUTIC MONOCLONAL ANTIBODY DEMAND BY THERAPEUTIC CLASS
      • Technology
      • Products
    • Encapsulated Parenteral Formulations
      • Table ENCAPSULATED PARENTERAL PRODUCT DEMAND BY TYPE & THERAPEUTIC CLASS
      • Polymer-Protected Formulations
      • Liposomes
    • Infusion Products
      • Table INFUSION PRODUCT DEMAND BY TYPE
      • IV Administration Sets
      • Premixed IV Solutions
      • Infusion Pumps
      • Other Infusion Products
    • Parenteral Devices
      • Table PARENTERAL DEVICE DEMAND BY TYPE
      • Prefillable Syringes
      • Hypodermic Syringes
      • IV Catheters
      • Other Parenteral Devices
  • OTHER DRUG DELIVERY PRODUCTS
    • General
      • Table OTHER DRUG DELIVERY PRODUCT DEMAND BY TYPE
    • Inhalation Drug Delivery Products
      • Table INHALATION DRUG DELIVERY PRODUCT DEMAND BY TYPE
      • Dry Powder Formulations
        • Table DRY POWDER INHALER DEMAND
      • Metered Dose Formulations
        • Table METERED DOSE INHALER DEMAND
    • Transdermal Drug Delivery Products
      • Table TRANSDERMAL DRUG DELIVERY PRODUCT DEMAND BY THERAPEUTIC CLASS
      • Transdermal Technologies
      • Central Nervous System Agents
      • Hormones & Related Agents
      • Cardiovascular Agents
      • Other Transdermal Patches
    • Implantable Drug Delivery Products
      • Table IMPLANTABLE DRUG DELIVERY PRODUCT DEMAND BY TYPE
      • Drug Inserts
        • Table DRUG INSERT DEMAND BY THERAPEUTIC CLASS
      • Drug-Eluting Stents
        • Table DRUG-ELUTING STENT DEMAND
      • Other Implantable Drug Delivery Products
        • Table OTHER IMPLANTABLE DRUG DELIVERY PRODUCT DEMAND BY TYPE
  • APPLICATIONS
    • General
      • Table DRUG DELIVERY PRODUCT DEMAND BY THERAPEUTIC CLASS
      • Table CHART VII-1 DRUG DELIVERY PRODUCT DEMAND BY THERAPEUTIC CLASS, 2014
    • Central Nervous System Agents
      • Table CENTRAL NERVOUS SYSTEM DRUG DELIVERY PRODUCT DEMAND BY TYPE
      • Controlled-Release Formulations
      • Other Oral Drug Delivery Products
      • Transdermal Formulations
      • Monoclonal Antibodies & Polymer Encapsulated Therapies
      • Liposomes
      • Other Drug Delivery Products
    • Hormones & Related Agents
      • Table HORMONE & RELATED DRUG DELIVERY PRODUCT DEMAND BY TYPE
      • Anticancer Monoclonal Antibodies
      • Encapsulated Polymers
      • Liposomes
      • Insulin Pen Injectors
      • Controlled-Release & Other Oral Drug Delivery Products
      • Transdermal Hormones & Related Agents
      • Other Drug Delivery Products
    • Respiratory Agents
      • Table RESPIRATORY DRUG DELIVERY PRODUCT DEMAND BY TYPE
      • Dry Powder Inhalers
      • Metered Dose Inhalers
      • Monoclonal Antibodies
    • Anti-Infective Agents
      • Table ANTI-INFECTIVE DRUG DELIVERY PRODUCT DEMAND BY TYPE
    • Cardiovascular Agents
      • Table CARDIOVASCULAR DRUG DELIVERY PRODUCT DEMAND BY TYPE
      • Controlled-Release Formulations
      • Monoclonal Antibodies
      • Drug-Eluting Stents
      • Transdermal Patches
    • Gastrointestinal Agents
      • Table GASTROINTESTINAL DRUG DELIVERY PRODUCT DEMAND BY TYPE
    • Nutritional Agents
      • Table NUTRITIONAL PREPARATION DELIVERY PRODUCT DEMAND BY TYPE
    • Other Pharmaceuticals
      • Table OTHER APPLICATION DRUG DELIVERY PRODUCT DEMAND BY TYPE
  • INDUSTRY STRUCTURE
    • General
      • Table US DRUG DELIVERY PRODUCT SALES BY COMPANY, 2014
    • Market Share
      • Table CHART VIII-1 DRUG DELIVERY FORMULATIONS, US MARKET SHARE, 2014
      • Table CHART VIII-2 DRUG DELIVERY DEVICES, US MARKET SHARE, 2014
    • Competitive Strategies
    • Mergers & Acquisitions
      • Table SELECTED ACQUISITIONS & DIVESTITURES
    • Licensing & Related Agreements
      • Table SELECTED COOPERATIVE AGREEMENTS
    • Marketing & Distribution
    • Manufacturing
    • Company Profiles
      • Abbott Laboratories
      • AbbVie Incorporated
      • Adare Pharmaceuticals Incorporated
      • Allergan plc
      • Amgen Incorporated
      • AptarGroup Incorporated
      • AstraZeneca plc
      • Baxter International Incorporated
      • Becton, Dickinson, and Company
      • Boehringer Ingelheim GmbH
      • Braun (B.) Melsungen AG
      • Bristol-Myers Squibb Company
      • Evonik Industries AG
      • Gerresheimer AG
      • Gilead Sciences Incorporated
      • GlaxoSmithKline plc
      • Johnson & Johnson
      • Lilly (Eli) and Company
      • Merck & Company Incorporated
      • Nitto Denko Corporation
      • Novartis AG
      • Novo Nordisk A/S
      • Pfizer Incorporated
      • Roche Holding Limited
      • Sanofi
      • Teva Pharmaceutical Industries Limited
      • 3M Company
      • Unilife Corporation
      • Vetter Pharma International GmbH
      • West Pharmaceutical Services Incorporated
    • Additional Companies in the Drug Delivery Product Market

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report